Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Werner

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
European Radiology|June 5, 2013
Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrenceIngfrid S Haldorsen, Renate Grüner, Jenny A Husby, et al.
British Journal of Cancer|March 15, 2012
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeC Krakstad, J Trovik, E Wik, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
British Journal of Cancer|February 11, 2020
Development of prediction models for lymph node metastasis in endometrioid endometrial carcinomaHege F Berg, Zhenlin Ju, Madeleine Myrvold, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 5, 2017
Type of vascular invasion in association with progress of endometrial cancerNicole C M Visser, Henrica M J Werner, Camilla Krakstad, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trialJone Trovik, Elisabeth Wik, Henrica M J Werner, et al.
American Journal of Obstetrics and Gynecology|August 17, 2021
Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort studyDavid Forsse, Mark L Barbero, Henrica M J Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinomaElisabeth Wik, Maria B Ræder, Camilla Krakstad, et al.
Plos One|November 2, 2018
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancerKanthida Kusonmano, Mari K Halle, Elisabeth Wik, et al.
British Journal of Cancer|October 27, 2012
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancerE Birkeland, E Wik, S Mjøs, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
European Radiology|June 5, 2013
Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrenceIngfrid S Haldorsen, Renate Grüner, Jenny A Husby, et al.
British Journal of Cancer|March 15, 2012
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeC Krakstad, J Trovik, E Wik, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
British Journal of Cancer|February 11, 2020
Development of prediction models for lymph node metastasis in endometrioid endometrial carcinomaHege F Berg, Zhenlin Ju, Madeleine Myrvold, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 5, 2017
Type of vascular invasion in association with progress of endometrial cancerNicole C M Visser, Henrica M J Werner, Camilla Krakstad, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trialJone Trovik, Elisabeth Wik, Henrica M J Werner, et al.
American Journal of Obstetrics and Gynecology|August 17, 2021
Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort studyDavid Forsse, Mark L Barbero, Henrica M J Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinomaElisabeth Wik, Maria B Ræder, Camilla Krakstad, et al.
Plos One|November 2, 2018
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancerKanthida Kusonmano, Mari K Halle, Elisabeth Wik, et al.
British Journal of Cancer|October 27, 2012
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancerE Birkeland, E Wik, S Mjøs, et al.
Pageof 10